Clinical trial
Donor Umbilical Cord Blood Transplant in Treating Patients With Hematologic…
NCT00290628 · Masonic Cancer Center, University of Minnesota, Other · Terminated
Key facts
| NCT number | NCT00290628 |
|---|---|
| Title | Donor Umbilical Cord Blood Transplant in Treating Patients With Hematologic Cancer |
| Official title | Transplantation of Umbilical Cord Blood From Related and Unrelated Donors |
| Lead sponsor | Masonic Cancer Center, University of Minnesota, Other |
| Collaborators | National Cancer Institute (NCI) NIH |
| Status | Terminated |
| Study type | Interventional |
| Conditions | Chronic Myeloproliferative Disorders, Diamond-blackfan Anemia, Fanconi Anemia, Graft Versus Host Disease, Leukemia, Lymphoma, Multiple Myeloma and Plasma Cell Neoplasm, Myelodysplastic Syndromes, Myelodysplastic/Myeloproliferative Diseases |
| Intervention type | Drug, Procedure |
| Interventions | anti-thymocyte globulin, busulfan, cyclophosphamide, cyclosporine, filgrastim, melphalan, methylprednisolone, mycophenolate mofetil, radiation therapy, umbilical cord blood transplantation |
| Enrollment | 43 |
| Start date | Oct 1, 1999 |
| Primary completion | Apr 1, 2007 |
| Completion | Apr 1, 2007 |
| First posted | Feb 13, 2006 |
| Last update posted | Nov 29, 2017 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: